Literature DB >> 6324317

Genital herpes: pathogenesis and chemotherapy in the guinea pig model.

G D Hsiung, D R Mayo, H L Lucia, M L Landry.   

Abstract

Genital herpes is different from other common venereal diseases in that there is no cure. As yet the natural history of genital herpes is not well understood. There are many unanswered questions regarding the biology of the disease; the virulence of the virus strains, individual host responses, and means for prevention and control all require further investigation. The study of genital herpes has been greatly aided in recent years by the development of animal models. The clinical and pathologic features of acute and recurrent genital disease of guinea pigs inoculated with low doses of herpes simplex virus are similar to those seen in human infection. Therefore, questions not readily studied in human infection--such as latent infection in the nervous system, the natural history, prevention, and treatment of neonatal herpes, the effects of immunosuppression on herpes infection, and the efficacy and toxicity of antiviral drugs and vaccines--are amenable to study in the guinea pig model. The applications of this animal model and its relevance to human disease are herein reviewed.

Entities:  

Mesh:

Year:  1984        PMID: 6324317     DOI: 10.1093/clinids/6.1.33

Source DB:  PubMed          Journal:  Rev Infect Dis        ISSN: 0162-0886


  13 in total

Review 1.  Innate Immune Mechanisms and Herpes Simplex Virus Infection and Disease.

Authors:  Evelyn A Kurt-Jones; Megan H Orzalli; David M Knipe
Journal:  Adv Anat Embryol Cell Biol       Date:  2017       Impact factor: 1.231

2.  Antiviral activity of 5-ethyl-2'-deoxyuridine against herpes simplex viruses in cell culture, mice, and guinea pigs.

Authors:  R F Schinazi; R T Scott; J Peters; V Rice; A J Nahmias
Journal:  Antimicrob Agents Chemother       Date:  1985-10       Impact factor: 5.191

3.  Activity of (+)-cyclaradine (Sch 31172) against herpes simplex virus in vitro and in vivo.

Authors:  J Schwartz; M Ostrander; N J Butkiewicz; M Lieberman; C Lin; J Lim; G H Miller
Journal:  Antimicrob Agents Chemother       Date:  1987-01       Impact factor: 5.191

4.  Oral acyclovir therapy of genital herpes simplex virus type 2 infections in guinea pigs.

Authors:  M N Ellis; D W Barry
Journal:  Antimicrob Agents Chemother       Date:  1985-02       Impact factor: 5.191

Review 5.  Animal models of herpes simplex virus immunity and pathogenesis.

Authors:  Christina M Kollias; Richard B Huneke; Brian Wigdahl; Stephen R Jennings
Journal:  J Neurovirol       Date:  2014-11-12       Impact factor: 2.643

6.  Efficacy of the acyclic guanosine analog buciclovir [(R)-9-(3,4-dihydroxybutyl)guanine] in experimental genital herpes.

Authors:  B Lundgren; A C Ericson; M Berg; R Datema
Journal:  Antimicrob Agents Chemother       Date:  1986-02       Impact factor: 5.191

Review 7.  Prospects and perspectives for development of a vaccine against herpes simplex virus infections.

Authors:  Shane C McAllister; Mark R Schleiss
Journal:  Expert Rev Vaccines       Date:  2014-07-31       Impact factor: 5.217

Review 8.  The impact of cell culture sensitivity on rapid viral diagnosis: a historical perspective.

Authors:  G D Hsiung
Journal:  Yale J Biol Med       Date:  1989 Mar-Apr

9.  The Characteristics of Herpes Simplex Virus Type 1 Infection in Rhesus Macaques and the Associated Pathological Features.

Authors:  Shengtao Fan; Hongzhi Cai; Xingli Xu; Min Feng; Lichun Wang; Yun Liao; Ying Zhang; Zhanlong He; Fengmei Yang; Wenhai Yu; Jingjing Wang; Jumin Zhou; Qihan Li
Journal:  Viruses       Date:  2017-01-30       Impact factor: 5.048

10.  Differential expression of mRNA and miRNA in guinea pigs following infection with HSV2v.

Authors:  Lin Kuang; Yihui Deng; Xiaodan Liu; Zhixiang Zou; Lan Mi
Journal:  Exp Ther Med       Date:  2017-07-19       Impact factor: 2.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.